Skip to content

Clinical trials

Expanded access trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Phase: Expanded access Country / region: Germany Clear all

34 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20051
20062

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
No longer available17
Approved for marketing10
Available7

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals5
Bayer2
BioMarin Pharmaceutical2
Eli Lilly and Company2
Pfizer2
SpringWorks Therapeutics, Inc., a healthcare company of Merck KGaA, Darmstadt, Germany2
Tibotec Pharmaceuticals, Ireland2
U.S. Army Medical Research and Development Command2
AIO-Studien-gGmbH1
Amgen1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Breast Neoplasms3
COVID-192
Carcinoma, Non-Small-Cell Lung2
Carcinoma, Renal Cell2
Multiple Myeloma2
Recurrence2
Adenocarcinoma1
Angioedema1
Angioedemas, Hereditary1
Carcinoma, Medullary1

Trials

Showing 76 to 34 of 34. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.